Multiparametric analysis of CD8
CD8+ T cells
chronic lymphocytic leukemia
multidimensional phenotyping
phenotypic signature
supervised learning
Journal
Oncoimmunology
ISSN: 2162-4011
Titre abrégé: Oncoimmunology
Pays: United States
ID NLM: 101570526
Informations de publication
Date de publication:
Historique:
received:
05
11
2018
revised:
10
12
2018
accepted:
08
01
2019
entrez:
26
3
2019
pubmed:
25
3
2019
medline:
25
3
2019
Statut:
epublish
Résumé
CD8
Identifiants
pubmed: 30906665
doi: 10.1080/2162402X.2019.1570774
pii: 1570774
pmc: PMC6422371
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Pagination
e1570774Références
Br J Haematol. 2001 Mar;112(4):959-64
pubmed: 11298591
Nat Immunol. 2002 Nov;3(11):991-8
pubmed: 12407406
Blood. 2003 Aug 1;102(3):1057-63
pubmed: 12689926
J Immunol Methods. 1992 Sep 18;154(1):7-10
pubmed: 1401946
Cancer Immunol Immunother. 2006 Feb;55(2):210-20
pubmed: 15906026
Bioinformatics. 2005 Oct 15;21(20):3940-1
pubmed: 16096348
J Clin Invest. 2008 Jul;118(7):2427-37
pubmed: 18551193
J Immunother. 2009 Apr;32(3):302-9
pubmed: 19242370
Semin Cancer Biol. 2010 Dec;20(6):431-8
pubmed: 20920582
Immunol Lett. 2011 Jan 30;134(2):137-44
pubmed: 20923685
Blood. 2011 Jan 13;117(2):563-74
pubmed: 20940416
Blood. 2011 Apr 7;117(14):3836-46
pubmed: 21270444
Mol Med. 2011;17(11-12):1374-82
pubmed: 21968788
Clin Cancer Res. 2012 Feb 1;18(3):678-87
pubmed: 22190592
Immunity. 2012 Jan 27;36(1):142-52
pubmed: 22265676
Blood. 2012 Mar 15;119(11):2590-4
pubmed: 22279054
Leuk Lymphoma. 2012 Sep;53(9):1785-94
pubmed: 22397719
Nat Rev Cancer. 2012 Mar 15;12(4):298-306
pubmed: 22419253
J Immunol Methods. 2012 Nov 30;385(1-2):79-89
pubmed: 22922462
Blood. 2013 Feb 28;121(9):1612-21
pubmed: 23247726
Immunity. 2013 Jul 25;39(1):1-10
pubmed: 23890059
Immunity. 2013 Jul 25;39(1):49-60
pubmed: 23890063
Semin Cancer Biol. 2014 Feb;24:71-81
pubmed: 24018164
Cancer Immunol Immunother. 2013 Nov;62(11):1697-1709
pubmed: 24022692
Int J Cancer. 2014 Nov 15;135(10):2370-9
pubmed: 24723150
Br J Haematol. 2015 Aug;170(4):515-22
pubmed: 25940792
Blood. 2015 Jul 9;126(2):212-21
pubmed: 25979947
Leukemia. 2016 Feb;30(2):492-500
pubmed: 26369987
Leukemia. 2016 Apr;30(4):833-43
pubmed: 26582643
Cell Rep. 2016 Apr 5;15(1):9-18
pubmed: 27052167
Oncotarget. 2016 Jun 28;7(26):40558-40570
pubmed: 27302925
Crit Rev Oncol Hematol. 2016 Aug;104:169-82
pubmed: 27370174
Haematologica. 2017 Mar;102(3):562-572
pubmed: 27927767
Nature. 2017 Jan 18;541(7637):321-330
pubmed: 28102259
Clin Cancer Res. 2017 Aug 1;23(15):4416-4428
pubmed: 28213366
Cell Rep. 2017 Apr 4;19(1):203-217
pubmed: 28380359
J Clin Invest. 2017 Aug 1;127(8):3052-3064
pubmed: 28714866
J Immunol. 2018 Jan 1;200(1):347-354
pubmed: 29141863
Nat Immunol. 2018 Jan;19(1):10-19
pubmed: 29242543
Nat Med. 2018 May;24(5):563-571
pubmed: 29713085
Leuk Res. 1998 Feb;22(2):175-84
pubmed: 9593474